▼ -3.31% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Nu Skin Enterprises in the last 3 months. The average price target is $57.00, with a high forecast of $66.00 and a low forecast of $41.00. The average price target represents a -3.31% upside from the last price of $58.95.
The current consensus among 7 polled investment analysts is to hold stock in Nu Skin Enterprises. This Hold consensus rating has held steady for over two years.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.